imsidolimab

WASHINGTON, May 27, 2026 Vanda Pharmaceuticals Inc. has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...

WASHINGTON, April 28, 2026 Vanda Pharmaceuticals Inc. has announced the publication of pivotal Phase III clinical data evaluating imsidolimab,...